Munich Re Life US acquired Clareto for $123 million on April 12, 2022, to bolster its healthcare information exchange capabilities. The acquisition strengthens Munich Re's position in the life insurance industry by integrating Clareto’s record retrieval services.
| Acquirer | Munich Re Life US (DE) |
|---|---|
| Target | Clareto (US) |
| Deal value | $123 million |
| Type of deal | Acquisition |
| Date closed | April 12, 2022 |
| Buy-side financial advisors | Not disclosed |
| Sell-side financial advisors | Not disclosed |
| Buy-side legal advisors | Clifford Chance, Paul Weiss Rifkind Wharton & Garrison |
| Sell-side legal advisors | Willkie Farr & Gallagher |
Deal mechanics
Munich Re Life US completed the acquisition of Clareto, a U.S.-based provider of health information exchange services, for $123 million. The deal aims to enhance Munich Re's ability to retrieve medical records and streamline underwriting processes for life insurance.
Strategic rationale
The acquisition of Clareto is part of Munich Re Life US’s strategy to deepen its presence in the healthcare technology sector. By integrating Clareto, Munich Re can improve access to patient data and refine its risk assessment capabilities within the U.S. market.
Financial context
Munich Re has a history of strategic acquisitions aimed at expanding its technological footprint in North America. The $123 million deal is consistent with the company’s recent focus on integrating advanced healthcare information systems to support life insurance underwriting processes.
Advisors
The buy-side legal counsel for Munich Re Life US included Clifford Chance and Paul Weiss Rifkind Wharton & Garrison. Willkie Farr & Gallagher served as the sell-side legal advisor for Clareto.
Outlook
Munich Re’s acquisition of Clareto represents a significant step in its efforts to enhance digital capabilities within the healthcare and life insurance sectors. The deal is expected to drive operational efficiencies and provide competitive advantages in record retrieval services.